drugset / Trial / NCT01806857
Clinical Trial Nuedexta in Subjects With ALS
Phase 2
Completed
90 enrolled
Center for Neurologic Study, La Jolla, California,
ALS Association · collabState University of New York - Upstate Medical University · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether Nuedexta is effective in the treatment of symptoms (impaired speech, swallowing, and saliva control)associated with Amyotrophic Lateral Sclerosis (ALS).
Timeline
- Start
- 2013-04
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | — | Oral |